Cypher stent safe despite clotting cases, says FDA
This article was originally published in Clinica
Executive Summary
The US FDA has clarified its position on the Cypher drug-coated stent made by Johnson & Johnson's Cordis, saying it believes the device to be "safe and effective when used according to the labelling". Concerns were sparked in October when it drew attention to reports of thrombosis following implantation (see Clinica No 1082, p 19).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.